Directory
>
Steve Krognes
Steve Krognes
Board Member | argenx
Cannes, Provence-Alpes-Côte d'Azur, France
Steve Krognes
Summary
Steve Krognes is a seasoned professional board member specializing in the biopharmaceutical and life sciences sectors. With extensive experience in acquisition integration and corporate finance, he has held leadership roles across multiple organizations, including CFO positions and board memberships. His strategic insights have been instrumental in guiding companies through mergers and acquisitions, particularly in emerging markets. Fluent in the complexities of financial modeling and risk management, Steve combines analytical rigor with a passion for innovation in healthcare. He is dedicated to professional mentoring and developing the next generation of leaders in the industry. Residing in Cannes, France, he enjoys the vibrant culture and networking opportunities the region offers.
Steve Krognes
Work Experience
Board Member at
Pliant Therapeutics, Inc.
June 2024 - Present
Board Member at
ClavystBio
September 2023 - Present
Board Member at
argenx
February 2023 - Present
Board Member at
Guardant Health
July 2022 - Present
Board Member at
Denali Therapeutics
May 2022 - Present
Board Member at
Gritstone bio
July 2018 - June 2024
Chief Financial Officer at
Denali Therapeutics
October 2015 - May 2022
Board Member at
Corvus Pharmaceuticals
March 2016 - June 2021
Trustee Board of Trustees at
California Academy Of Sciences
June 2014 - June 2018
Board of Directors and Board Executive Committee at
California Life Science Association
September 2010 - September 2015
CFO at
Genentech Foundation
April 2009 - September 2015
Head of M&A at
ROCHE LEON HOLDINGS
January 2004 - April 2009
Director M&A at
Danske Bank
July 2002 - December 2003
Venture Capitalist at
Pylonia Ventures
April 2000 - June 2002
Management consultant at
McKinsey & Company Inc
January 1996 - April 2000
Financial analyst at
Goldman Sachs
March 1993 - December 1995
Steve Krognes
Education
January 1997 - January 1998
University of Pennsylvania, Bsc
January 1990 - January 1993
Frequently Asked Questions about Steve Krognes
What is Steve Krognes email address?
Steve Krognes's primary email address is *************@roche.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Steve Krognes work for?
Steve Krognes is a Board Member at argenx, a company specializing in Commercial physical research.
Where Steve Krognes graduated from?
Steve Krognes holds a degree in Finance, General from Harvard Business School.
How can I directly contact Steve Krognes?
To contact Steve Krognes directly, you can use the email address *************@roche.com. Complete contact information is available upon registration with Muraena.
Is Steve Krognes an immigrant?
Yes, Steve Krognes is an immigrant and currently based in France
Who is Steve Krognes?
Steve Krognes is a seasoned professional board member specializing in the biopharmaceutical and life sciences sectors. With extensive experience in acquisition integration and corporate finance, he has held leadership roles across multiple organizations, including CFO positions and board memberships. His strategic insights have been instrumental in guiding companies through mergers and acquisitions, particularly in emerging markets. Fluent in the complexities of financial modeling and risk management, Steve combines analytical rigor with a passion for innovation in healthcare. He is dedicated to professional mentoring and developing the next generation of leaders in the industry. Residing in Cannes, France, he enjoys the vibrant culture and networking opportunities the region offers.
Steve`s contact details
*************@roche.com
*************@denalitherapeutics.com
Colleagues
Chief Scientific Officer
Member Board of Directors
VP, Global Head of CMC and Supply Chain
Board Member
Vice President, Health Economics & Outcomes Research
VP Clinical Development
Medical Affairs Executive Director, Hematology
VP, Global Head Trial Operations
Chief Operating Officer
Vice President, Head of Global Patient Safety